References
- Lee SW, Yun MH, Jeong SW, et al. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM (TM) using polymer-based delivery system. J Control Release. 2011;155:262–271.
- Fang G, Tang B, Liu Z, et al. Novel hydrophobin-coated docetaxel nanoparticles for intravenous delivery: in vitro characteristics and in vivo performance. Eur J Pharm Sci. 2014;60:1–9.
- Chen L, Sha X, Jiang X, et al. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation. Int J Nanomed. 2013;8:73.
- Chen Y, Chen J, Cheng Y, et al. A lyophilized sterically stabilized liposome-containing docetaxel: in vitro and in vivo evaluation. J Liposome Res. 2017;27:64–73.
- Ouahab A, Shao C, Shen Y, et al. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel. Drug Dev Ind Pharm. 2014;40:860–868.
- Hwang HY, Kim IS, Kwon IC, et al. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2008;128:23–31.
- Yin YM, Cui FD, Mu CF, et al. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release. 2009;140:86–94.
- Mosallaei N, Jaafari MR, Hanafi-Bojd MY, et al. Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations. J Pharm Sci. 2013;102:1994–2004.
- Huynh L, Leroux JC, Allen C. Enhancement of docetaxel solubility via conjugation of formulation-compatible moieties. Org Biomol Chem. 2009;7:3437–3446.
- Shi J, Zhang J, Shen Y, et al. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery. Drug Deliv. 2015;22:168–181.
- Tong SW, Xiang B, Dong DW, et al. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Int J Pharm. 2012;434:413–419.
- Biswas S, Kumari P, Lakhani PM, et al. Recent advances in polymeric micelles for anti-cancer drug delivery. Eur J Pharm Sci. 2016;83:184–202.
- Wang M, Lu P, Wu B, et al. High efficiency and low toxicity of polyethyleneimine modified Pluronics (PEI–Pluronic) as gene delivery carriers in cell culture and dystrophic mdx mice. J Mater Chem. 2012;22:6038–6046.
- Yang Z, Zhu J, Sriadibhatla S, et al. Promoter-and strain-selective enhancement of gene expression in a mouse skeletal muscle by a polymer excipient Pluronic P85. J Control Release. 2005;108:496–512.
- Alakhova DY, Zhao Y, Li S, et al. Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia. PLoS One. 2013;8:e72238.
- Chen Y, Zhang W, Huang Y, et al. The therapeutic effect of methotrexate-conjugated Pluronic-based polymeric micelles on the folate receptor-rich tumors treatment. Int J Nanomed. 2015;10:4043.
- Zhang W, Dong D, Li P, et al. Novel pH-sensitive polysialic acid based polymeric micelles for triggered intracellular release of hydrophobic drug. Carbohydr Polym. 2016;139:75–81.
- Kiss JZ, Rougon G. Cell biology of polysialic acid. Curr Opin Neurobiol. 1997;7:640–646.
- Colley KJ, Kitajima K, Sato C. Polysialic acid: biosynthesis, novel functions and applications. Crit Rev Biochem Mol Biol. 2014;49:498–532.
- Fernandes AI, Gregoriadis G. The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics. Int J Pharm. 2001;217:215–224.
- Fernandes AI, Gregoriadis G. Polysialylated asparaginase: preparation, activity and pharmacokinetics. BBA. Protein Structure Mol Enzymol. 1997;1341:26–34.
- Zhang T, She Z, Huang Z, et al. Application of sialic acid/polysialic acid in the drug delivery systems. Asian J Pharm Sci. 2014;9:75–81.
- Sato C, Kitajima K. Disialic, oligosialic and polysialic acids: distribution, functions and related disease. J Biochem. 2013;154:115–136.
- Itoh N. The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease. Biol Pharm Bull. 2007;30:1819–1825.
- Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer. 2010;10:116–129.
- Ono S, Hane M, Kitajima K, et al. Novel regulation of fibroblast growth factor 2 (FGF2)-mediated cell growth by polysialic acid. J Biol Chem. 2012;287:3710–3722.
- Zhang T, Zhou S, Hu L, et al. Polysialic acid-modifying liposomes for efficient delivery of epirubicin, in-vitro characterization and in-vivo evaluation. Int J Pharm. 2016;515:449–459.
- Kilkenny C, Browne WJ, Cuthill IC, et al. Improving Bioscience Research Reporting: the ARRIVE Guidelines for Reporting Animal Research. PLoS Biol. 2010;8:e1000412.
- Song YZ, Tian QJ, Huang ZJ, et al. Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery system. Int J Nanomed. 2014;9:2307–2317.
- Kabanov AV, Batrakova EV, Miller DW. Pluronic((R)) block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv Drug Deliv Rev. 2003;55:151–164.
- Janas T, Nowotarski K, Janas T. Polysialic acid can mediate membrane interactions by interacting with phospholipids. Chem Phys Lipids. 2010;163:286–291.
- Nowotarski K, Sapon K, Kowalska M, et al. Membrane potential-dependent binding of polysialic acid to lipid monolayers and bilayers. Cell Mol Biol Lett. 2013;18:579–594.
- Bader RA, Silvers AL, Zhang N. Polysialic acid-based micelles for encapsulation of hydrophobic drugs. Biomacromolecules. 2011;12:314–320.
- Wei Z, Hao J, Yuan S, etet al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 2009;376:176–185.
- Oh KT, Bronich TK, Kabanov AV. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic((R)) block copolymers. J Control Release. 2004;94:411–422.
- Greco F, Arif I, Botting R, et al. Polysialic acid as a drug carrier: evaluation of a new polysialic acid–epirubicin conjugate and its comparison against established drug carriers. Polym Chem. 2013;4:1600–1609.
- Park K, Kim J-H, Nam YS, et al. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J Control Release. 2007;122:305–314.
- Chen Y, Sha X, Zhang W, et al. Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation. Int J Nanomed. 2013;8:1463.
- Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol. 2003;7:626–634.
- Park MH, Keum CG, Song JY, et al. A novel aqueous parenteral formulation of docetaxel using prodrugs. Int J Pharm. 2014;462:1–7.